PAM
LEGN icon

Panagora Asset Management’s Legend Biotech LEGN Stock Holding History

Panagora Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-139,893
Closed -$3.04M – 1221
2025
Q4 		$3.04M Buy
+139,893
New +$4.01M 0.01% 478
2022
Q4 		– Sell
-11,247
Closed -$459K – 1480
2022
Q3 		$459K Sell
11,247
-648
-5% -$30.4K ﹤0.01% 1164
2022
Q2 		$654K Hold
11,895
– – ﹤0.01% 1069
2022
Q1 		$432K Buy
+11,895
New +$470K ﹤0.01% 1262

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Panagora Asset Management's LEGN Position: Q1 2026 in Review

Panagora Asset Management sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 139,893 shares — an estimated $3.04M sold.

Panagora Asset Management first reported a position in LEGN in Q1 2022 and held it in 4 quarters. The position peaked at $3.04M in Q4 2025. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Panagora Asset Management reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Panagora Asset Management sold 139,893 Legend Biotech shares in Q1 2026, an estimated $3.04M.
  • Panagora Asset Management first reported a position in Legend Biotech in Q1 2022 and held it in 4 quarters.
  • Panagora Asset Management's Legend Biotech position peaked at $3.04M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.